BOYNTON BEACH, Fla., Nov. 14, 2003 (PRIMEZONE) -- Harvey Grossman, President and Chief Strategic Officer of Jacobson Resonance Enterprises, Inc. (OTCBB:JRSE) announces today that the Company's Canadian licensee Bio Resonance Technology, Inc. intends to enter into joint research projects with Technical Units from the Science and Technology Center Ukraine (STCU). Bio Resonance Technology, Inc. participated in a Canada Industrial Development Agency (CIDA) sponsored mission to the Ukraine in October. The Science & Technology Center in Ukraine (STCU) is an intergovernmental organization established by its Donor Countries (Canada, The European Union and the United States) dedicated to the non-proliferation of technologies and expertise related to weapons of mass destruction and their delivery systems by facilitating R&D projects and encouraging technology transfer and commercialization. In recognition of its important non-proliferation mission, government & non-government organizations have joined the STCU Countries in contributing financial, in-kind, and human resources to the STCU.
The STCU Donor Countries fund Regular Projects, and STCU Partners fund Partner Projects by soliciting scientific project proposals from institutes and scientists and provides funding along with STCU logistical support to the project teams in order to efficiently reach research goals. The STCU helps develop, finance, and monitor science and technology projects and programs that engage the former Soviet weapons community in peaceful civilian activities and facilitate their move into the global business environment.
Harvey Grossman states: "We are pleased that such an association has been established. The utilization of world-class scientists for the peaceful applications of Jacobson Resonance coincides with our corporate mission to alleviate human suffering. By increasing our research and development at a fraction of the standard costs, we potentially speed up the commercialization process which benefits the bottom line and our shareholders."
Quoting Alan Kotowich, President of Bio Resonance Technology, Inc: "Participation in the CIDA mission to the Ukraine has enhanced our ability to achieve our corporate goals. We plan to have these scientists undertake research studies that further verify the efficacy and safety of Jacobson Resonance in medical therapy and in agriculture, namely crop yield enhancement. We have discovered that an incredible resource of highly qualified scientists is now available to us at a fraction of North American costs. We fully expect to initiate this project with one or more Ukraine Technical Units. They have extensive experience in the study of electromagnetic fields that will be of tremendous benefit to us and to Jacobson Resonance Enterprises Inc."
JRSE is an emerging worldwide leader in magnetic resonance technology, whose main focus is the eradication of human suffering. The Company's technology base has the potential for multiple industry applications including the fields of medicine, spa and leisure arena, food and beverage, pharmaceuticals, energy and the environment.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The matters covered by such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements of the Company to differ materially from those contemplated or implied by such forward-looking statements. Included in these risks and other factors are funding availability, competition from better-financed companies and required regulatory clearances. For further information, contact Harvey Grossman at (561) 752.4141.